$1.02
At close: Jun 27 EDT
$0.9816
-0.04-3.76%
Pre-Market: 8:19 AM EDT
Comments
Loading...
Opus Genetics Earnings Estimates, EPS & Revenue | NASDAQ:IRD | Benzinga
Opus Genetics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 15
EPS Estimate
$-0.260
Quarterly Revenue Estimate
$4.27M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$13.65M
Analyze the earnings history of Opus Genetics using advanced sorting and filters.
Opus Genetics (IRD) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-15 | $-0.24 | $-0.29 | 17.2 % |
Opus Genetics (IRD) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-15 | $4.37M | $4.00M | 9.25 % |
FAQ
When is Opus Genetics (NASDAQ:IRD) reporting earnings?
Opus Genetics (IRD) is scheduled to report earnings on August 15, 2025. The last reported earnings were for reported on May 15, 2025 for Q1.
What were the latest earnings per share (EPS) for Opus Genetics (NASDAQ:IRD)?
The Actual EPS was $-0.24, which beat the estimate of $-0.29.
What were Opus Genetics’s (NASDAQ:IRD) revenues?
The Actual Revenue was $4.4M, which beat the estimate of $4M.
Browse earnings estimates, EPS, and revenue on all stocks.
